AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum
NCT: NCT07829640 · NOT_YET_RECRUITING
Brief Summary
This investigator-initiated, single-center study consists of a retrospective artificial intelligence model-development stage and a prospective physician reader-study stage. Deidentified chest CT examinations acquired during routine clinical care between January 1, 2021, and December 31, 2024, will be used to develop, validate, and lock artificial intelligence models for lung cancer-related imaging tasks. In the prospective stage, approximately 12 to 15 physicians with experience in chest CT interpretation will complete two reading sessions in randomized order: unaided interpretation and AI-assisted interpretation. The sessions will be separated by a washout period of at least 4 weeks. The primary objective is to compare diagnostic performance between AI-assisted and unaided interpretation. Secondary objectives include reading time, diagnostic confidence, inter-reader agreement, and errors related to incorrect AI suggestions. All readings will be performed in an offline research environment. AI outputs will not be used for patient care, and the study will not add imaging examinations, treatment, or follow-up for patients.
Frequently Asked Questions
What is AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum?
AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum is a clinical trial registered under NCT07829640. Current status: NOT_YET_RECRUITING.
What is the status of NCT07829640?
The current status of NCT07829640 (AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum) is: NOT_YET_RECRUITING.
When did AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum start?
AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.